Moderna Inc. Stock Falls 5.2%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. shed 5.2% to $54.07 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.5% to 51,947.25 and the NASDAQ Composite Index falling 0.6% to 24,975.82.

This was the stock's third consecutive day of losses.

Moderna Inc. closed 36.8% below its 52-week high of $85.60, which the company achieved on July 6th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.6% to $263.40, Pfizer Inc. fell 0.2% to $24.54, and Gilead Sciences Inc. fell 1.18% to $129.31.

Trading volume totaled 4.4 million, compared to the 50-day average of 7.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 24, 2026 16:35 ET (20:35 GMT)